Europe Glucagon-Like Peptide-1 (GLP-1) Agonists Market Share

Statistics for the 2023 & 2024 Europe Glucagon-Like Peptide-1 (GLP-1) Agonists market share, created by Mordor Intelligence™ Industry Reports. Europe Glucagon-Like Peptide-1 (GLP-1) Agonists share report includes a market forecast to 2030 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Europe GLP-1 Agonist Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Europe Glucagon-Like Peptide-1 (GLP-1) Agonists Industry Overview

The Europe GLP-1 market is consolidated, with major manufacturers, namely Eli Lilly, Sanofi, Novo Nordisk, AstraZeneca, etc., holding a presence in the region.

Europe Glucagon-Like Peptide-1 (GLP-1) Agonists Market Leaders

  1. Novo Nordisk

  2. AstraZeneca

  3. Eli lilly and Company

  4. Sanofi

  5. Pfizer

  6. *Disclaimer: Major Players sorted in no particular order
Europe Glucagon-Like Peptide-1 (GLP-1) Agonists Market Concentration

Europe GLP-1 Agonists Market Report Snapshots